Literature DB >> 33592896

Intraductal papillary neoplasm of intrahepatic bile ducts complicated by chronic disseminated intravascular coagulation and thrombosis: A case report.

Ming Xiao1, Aijun Sun2, Fan Yu3, Ying Xiao4, Lihong Li3, Dongyan Shen5, Canhong Xiang1, Jiahong Dong1.   

Abstract

RATIONALE: Intraductal papillary neoplasm of the bile ducts (IPNB) is a relatively rare tumor that is clinically characterized by digestive symptoms. The concurrent occurrence of chronic disseminated intravascular coagulation (DIC) with thrombosis is an extremely rare combination, reported in patients with IPNB. The clinical features of chronic DIC include microangiopathic hemolytic anemia, thrombocytopenia, and hypofibrinogenemia. Here, we report the case of a mucin-producing IPNB patient with hematological abnormalities. PATIENT CONCERNS: A 58-year-old male patient suffered from abdominal distension for more than 2 months with obstructive jaundice appearance. Abdominal contrast-enhanced computed tomography and magnetic resonance cholangiopancreatography showed a neoplasm in the right hepatic lobe. Multiple intravascular fillings were found in the inferior vena cava, pulmonary artery, and right atrium. Anemia and hypofibrinogenemia were discovered through routine laboratory tests. The count of platelets began to decline 25 days after admission, while 1 month after hospitalization, the patient developed abdominal pain, fever, and shock. DIAGNOSIS: Pathological examination demonstrated IPNB with a part of high-grade intraepithelial neoplasia. Cardiac and inferior vena cava emboli were diagnosed as thrombi without neoplastic cells. Immunohistochemically, tumor cells were positive for Vimentin (mesenchyme), CK7, CK19, MUC-1, MUC-5AC, MUC-6, S-100p (focal), Ki-67 (12%), and negative for Inhibin-α, ER, CK20, CEA, and MUC-2. Additionally, immunohistochemistry indicated that IPNB was a mucus-secretion gastric type. The laboratory tests confirmed the presence of chronic DIC.
INTERVENTIONS: The patient was given anticoagulant therapy before hepatectomy and right atrium thrombectomy was performed under cardiopulmonary bypass. OUTCOMES: After anticoagulant therapy, the levels of hemoglobin, platelet, and fibrinogen of the patient returned to normal. Hepatectomy and thrombus removal was successfully performed. Then, the patient was discharged 12 days after the operation. After 12 months of follow-up, the patient recovered well without any hematologic abnormalities and no signs of tumor recurrence were observed. LESSONS: IPNB may cause hematological complications, which can be easily misdiagnosed. It is essential to pay particular attention to the hematological abnormalities of patients with IPNB. Early detection and differential diagnosis of chronic DIC and thrombosis are necessary. We note that anticoagulant therapy coupled with surgery is an effective strategy to treat these complications.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33592896      PMCID: PMC7870212          DOI: 10.1097/MD.0000000000024454

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  19 in total

Review 1.  MUC1: the polymorphic appearance of a human mucin.

Authors:  F G Hanisch; S Müller
Journal:  Glycobiology       Date:  2000-05       Impact factor: 4.313

2.  Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH.

Authors:  J Thachil; A Falanga; M Levi; H Liebman; M Di Nisio
Journal:  J Thromb Haemost       Date:  2015-01-28       Impact factor: 5.824

Review 3.  Usefulness of novel tumour markers.

Authors:  J M Rhodes
Journal:  Ann Oncol       Date:  1999       Impact factor: 32.976

4.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines.

Authors:  H Wada; J Thachil; M Di Nisio; P Mathew; S Kurosawa; S Gando; H K Kim; J D Nielsen; C-E Dempfle; M Levi; C-H Toh
Journal:  J Thromb Haemost       Date:  2013-02-04       Impact factor: 5.824

Review 6.  Management of cancer-associated disseminated intravascular coagulation.

Authors:  Marcel Levi
Journal:  Thromb Res       Date:  2016-04       Impact factor: 3.944

7.  Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.

Authors:  M Levi; C H Toh; J Thachil; H G Watson
Journal:  Br J Haematol       Date:  2009-02-12       Impact factor: 6.998

Review 8.  Systematic Review and Meta-analysis of Current Experience in Treating IPNB: Clinical and Pathological Correlates.

Authors:  Alex N Gordon-Weeks; Keaton Jones; Elinor Harriss; Adrian Smith; Michael Silva
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

Review 9.  Mucins in neoplasms of pancreas, ampulla of Vater and biliary system.

Authors:  Dimitrios Moschovis; Giorgos Bamias; Ioanna Delladetsima
Journal:  World J Gastrointest Oncol       Date:  2016-10-15

10.  Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases.

Authors:  Koki Okazaki; Fumiaki Oka; Hideyuki Ishihara; Michiyasu Suzuki
Journal:  BMC Neurol       Date:  2018-10-04       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.